The FTSE 100 was little changed on Tuesday, stabilizing after two days of declines, supported by gains in healthcare and consumer goods stocks. AstraZeneca climbed 1.2% and GlaxoSmithKline rose 1.9%, while consumer staples Unilever and British American Tobacco advanced around 0.7% and over 1%, respectively. BP also gained more than 1% after reporting stronger-than-expected Q3 profits of $2.2 billion, announcing a $750 million share buyback, and confirming it is on track to exceed $4 billion in divestment proceeds this year following the $1.5 billion sale of US shale assets. Meanwhile, Chancellor Rachel Reeves’s speech ahead of the late-November budget offered few specifics but hinted at possible tax hikes. She cited years of economic mismanagement and global pressures while reiterating her “iron-clad” fiscal rules and commitment to reducing inflation and maintaining fiscal discipline, sending the pound toward $1.30.